Bristol-Myers (BMY) Stock Price Down Nearly 40% Over The Past Year. 2024 Stock Valuation

preview_player
Показать описание
Bristol-Myers (BMY) looking to bring new drugs to the market to turn the stock price around. Walkthrough my stock valuation for the company.


00:00 – Intro
00:18 – Financials
01:48 – Stock Valuation
04:14 – Other Fianacial Datapoints
06:04 – Portfolio Performance


The intrinsic values presented here serve as informational guidance and should not be solely relied upon for evaluating a company or making investment choices. Just like any investment endeavor, conducting thorough research, comprehending associated risks, reviewing financial reports, and seeking advice from investment experts, if needed, are essential steps before making any investment decisions.


The intrinsic value provided are for assisting investors in:


1. Comparing intrinsic values to their valuation.
2. Saving time identifying undervalued companies.
3. Avoiding overpaying too much for a stock.

$BMY
Рекомендации по теме
Комментарии
Автор

Solid and balanced analysis. The P/E is negative because of the 3 big acquisitions they made.

MisterBig